Celdara Medical, LLC
http://www.celdaramedical.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Celdara Medical, LLC
Celyad Signs Deal With Japan's Ono For CAR-T-Like Program
Celyad has struck a deal with Ono Pharmaceutical for certain rights to its allogeneic NKR-2 T-cell immunotherapy, a variation on traditional CAR-T approaches. The agreement eases some of the pressure from the recent late stage failure of Celyad's heart failure cell therapy.
GSK/Desano Tie-Up To Bring Large Dolutegravir Price Cuts
HIV drug Tivicay is expected to become cheaper in China under a recent manufacturing deal between ViiV and Desano. The Chinese firm expects to gain a 35% share of the global generic antiretroviral API supply market this year after patent licensing agreements with the Medicines Patent Pool.
Deals Shaping The Medical Industry, February 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.
More Than Two-Thirds Of Listed Pharma In China Reports Q1-3 Sales Growth
Among the 113 listed pharma in China, more than two thirds reported sales growth in the first three quarters of the year.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice